|
Reference
|
|
Abdallah, C.G., Sanacora, G., Duman, R.S., Krystal, J.H. (2015) Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics. Annual Review of Medicine, 66(1): 509-523
|
|
Ault, A. US Ketamine Clinics continue to mushroom with no regulation. Dostupno na: https://www.medscape.com/viewarticle/886750
|
|
Berger, F.M. (2016) Depression and antidepressant drugs. Clinical Pharmacology & Therapeutics, 18(3): 241-248
|
2
|
Berman, R.M., Cappiello, A., Anand, A., Oren, D.A., Heninger, G.R., Charney, D.S., Krystal, J.H. (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry, 47(4): 351-4
|
|
Bittl, J.A., Maron, D.J. (2017) Using Absolute Event Rates to See What Works in Cardiovascular Medicine ∗. Journal of the American College of Cardiology, 70(11): 1376-1378
|
|
Boland, R.J., Gaud, K.G., Keller, M.B. (2015) Antidepressants. u: Tasman, Allan; Kay, Jerald; Lieberman, Jeffrey A.; First, Michael B.; Riba, Michelle B. [ur.] Psychiatry, Chichester, UK: Wiley, str. 2052-2087
|
|
Brent, D.A. (2016) Antidepressants and Suicidality. Psychiatric Clinics of North America, 39(3): 503-512
|
|
Cipriani, A., Furukawa, T.A., Salanti, G., Chaimani, A., Atkinson, L.Z., Ogawa, Y., Leucht, S., Ruhe, H.G., Turner, E.H., Higgins, J.P.T., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K. (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet, 391(10128): 1357-1366
|
|
Citrome, L., Ketter, T. A. (2013) When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed. International Journal of Clinical Practice, 67(5): 407-411
|
|
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., Haddad, P., Katona, C., Lewis, G., Malizia, A., McAllister-Williams, R., Ramchandani, P., Scott, J., Taylor, D., Uher, R. (2015) Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology, 29(5): 459-525
|
|
Driessen, E., Hollon, S.D. (2010) Cognitive Behavioral Therapy for Mood Disorders: Efficacy, Moderators and Mediators. Psychiatric Clinics of North America, 33(3): 537-555
|
|
Goldberg, J.F., Rush, A. J. (2017) Addressing the unmet needs of current antidepressants: does neuroscience help or hinder clinical psychopharmacology research?. Expert Opinion on Pharmacotherapy, 18(14): 1417-1420
|
|
Gould, S., Friedman, L.F. Something startling is going on with antidepressant use around the world. Business Insider, Dostupno na: http://www.businessinsider.com/countries-largest-antidepressant-drug-users-2016-2
|
|
Gupta, S., Wallace, R., Sloshower, J. (2017) Online Sales of Unscheduled Pharmaceutical Agents. Journal of Addiction Medicine, 11(5): 411-412
|
|
Hengartner, M.P. (2017) Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants’ Efficacy and Harm. Frontiers in Psychiatry, 8:
|
1
|
Khan, A., Fahl, M.K., Faucett, J., Khan, S.S., Brown, W.A. (2017) Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013. World Psychiatry, 16(2): 181-192
|
|
Kirsch, I. (2008) Challenging received wisdom: Antidepressants and the placebo effect. Mcgill J Med, 11: 219-22
|
|
Kirsch, I. (2008) Antidepressant drugs work, but they are not clinically effective. Br J Hosp Med (Lond), 69: 359
|
|
Krogh, J., Hjorthøj, C., Speyer, H., Gluud, C., Nordentoft, M. (2017) Exercise for patients with major depression: a systematic review with meta-analysis and trial sequential analysis. BMJ Open, 7(9): e014820
|
|
Krystal, J.H., Sanacora, G., Duman, R.S. (2013) Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond. Biological Psychiatry, 73(12): 1133-1141
|
|
Lee, S.H., Paz-Filho, G., Mastronardi, C., Licinio, J., Wong, M. (2016) Is increased antidepressant exposure a contributory factor to the obesity pandemic?. Translational Psychiatry, 6(3): e759
|
|
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., Duman, R. S. (2010) mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists. Science, 329(5994): 959-964
|
|
Linde, K., Kriston, L., Rucker, G., Jamil, S., Schumann, I., Meissner, K., Sigterman, K., Schneider, A. (2015) Efficacy and Acceptability of Pharmacological Treatments for Depressive Disorders in Primary Care: Systematic Review and Network Meta-Analysis. Annals of Family Medicine, 13(1): 69-79
|
|
Meister, R., Jansen, A., Härter, M., Nestoriuc, Y., Kriston, L. (2017) Placebo and nocebo reactions in randomized trials of pharmacological treatments for persistent depressive disorder. A meta-regression analysis. Journal of Affective Disorders, 215: 288-298
|
|
Pereira, V.S., Hiroaki-Sato, V.A. (2018) A brief history of antidepressant drug development: from tricyclics to beyond ketamine. Acta Neuropsychiatrica, str. 1-16
|
|
Pratt, L.A., Brody, D.J., Gu, Q. (2011) Antidepressant use in persons aged 12 and over: United States, 2005-2008. NCHS Data Brief, No. 76, October. Dostupno na: https://www.cdc.gov/nchs/data/databriefs/db76.pdf
|
|
Rutherford, B.R., Wall, M.M., Brown, P.J., Choo, T., Wager, T.D., Peterson, B.S., Chung, S., Kirsch, I., Roose, S.P. (2017) Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials. American Journal of Psychiatry, 174(2): 135-142
|
|
Samuels, B.A., Nautiyal, K.M., Kruegel, A.C., Levinstein, M.R., Magalong, V.M., Gassaway, M.M., Grinnell, S.G., Han, J., Ansonoff, M.A., Pintar, J.E., Javitch, J.A., Sames, D., Hen, R. (2017) The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor. Neuropsychopharmacology, 42(10): 2052-2063
|
|
Turner, E.H., Matthews, A.M., Linardatos, E., Tell, R.A., Rosenthal, R. (2008) Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy. New England Journal of Medicine, 358(3): 252-260
|
|
van Loo, H.M., de Jonge, P., Romeijn, J., Kessler, R.C., Schoevers, R.A. (2012) Data-driven subtypes of major depressive disorder: a systematic review. BMC Medicine, 10(1):
|
|
Wilson, E., Lader, M. (2015) A review of the management of antidepressant discontinuation symptoms. Therapeutic Advances in Psychopharmacology, 5(6): 357-368
|
|
|
|